(Q46987172)

27 December 2017

title

N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity (English)

1 reference

27 December 2017

author name string

Taccone-Gallucci M

1

1 reference

27 December 2017

Manca-di-Villahermosa S

2

1 reference

27 December 2017

Battistini L

3

1 reference

27 December 2017

Stuffler RG

4

1 reference

27 December 2017

Tedesco M

5

1 reference

27 December 2017

Maccarrone M

6

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

27 December 2017

published in

Kidney International

1 reference

27 December 2017

volume

69

1 reference

27 December 2017

issue

8

1 reference

27 December 2017

page(s)

1450-1454

1 reference

27 December 2017

Fatty acid composition of the plasma lipids in Greenland Eskimos

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Cardiovascular Effects of n-3 Fatty Acids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration route

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Arachidonate cascade, apoptosis, and vitamin E in peripheral blood mononuclear cells from hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Vitamin E supplementation increases LDL resistance to ex vivo oxidation in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of the arachidonate cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Platelet lipid peroxidation in haemodialysis patients: effects of vitamin E supplementation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Involvement of 5-lipoxygenase in programmed cell death of cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Cholesterol, but not its esters, triggers programmed cell death in human erythroleukemia K562 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Induction of apoptosis by bleomycin in resting and cycling human lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000291

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000291

1 reference

27 December 2017

Dimensions Publication ID

1013707837

0 references

1 reference

27 December 2017